Healthcare Distribution Alliance – Patients Move Us.
Share Print
DMC 2018

Conferences

DMC and Expo | March 4-7 | Austin, Texas

Speakers

James Arnold  
James A. Arnold, Section Chief, Liaison and Policy Section, Diversion Control Division, U.S. Drug Enforcement Administration (DEA)

Jim currently serves as Chief of the Policy and Liaison Section, Diversion Control Division, Drug Enforcement Administration (DEA) at DEA Headquarters in Washington, DC.  Jim has also served as the Chief of the Policy Unit and the Chief of the Regulatory Unit at DEA Headquarters, as well as in various other investigative and supervisory positions at the DEA New Jersey Field Division, Newark, New Jersey.  His efforts in the New Jersey Field Division focused on administrative, civil, and criminal investigations of DEA registrants and other individuals and organizations who were engaged in violations of the Controlled Substances Act and/or with other illegal activities with legitimate, and illegal, controlled substances and listed chemicals.  

With over 28 years of experience with the DEA Jim has spoken nationwide on numerous regulatory subjects; has coordinated and spearheaded investigations on various regulatory issues of nationwide importance for DEA and the Department of Justice; was intimately involved with various investigations and prosecutions of DEA registrants at the height of the opioid prescription drug problem in south Florida in 2011 and 2012; and has been an Instructor at the DEA Justice Training Center in Quantico, Virginia, for Intelligence Research Specialists, Special Agents of Tactical Diversion Squads, and new Basic Diversion Investigator Classes since July of 1999.    
Jim is a proud graduate of West Chester State University, and Drew University, where he received a Master’s Degree. Jim has been the recipient of numerous awards and commendations throughout his DEA career in recognition of many successful investigations and prosecutions, and for his leadership, performance and commitment to public service.

Charles Best  
Charles Best, Founder and CEO, DonorsChoose.org

Charles Best leads DonorsChoose.org, the pioneering crowdfunding nonprofit where anyone can help a classroom in need. At DonorsChoose.org, public school teachers create classroom project requests and donors can choose the projects they want to support.

Best launched the platform in 2000 out of a Bronx public high school where he taught history. Today, more than two thirds of U.S. public schools have at least one teacher who has created a project request on DonorsChoose.org, and 1.8 million people have donated $360 million to classroom projects reaching 16 million students.

DonorsChoose.org is one of Oprah Winfrey's "Ultimate Favorite Things" and was the first charity to be featured on the cover of Fast Company as one of the "50 Most Innovative Companies in the World.”

For three years, FORTUNE magazine has named Best to its "40 Under 40 Hottest Rising Stars in Business.” He has received the John F. Kennedy “New Frontier Award,” which honors young Americans who are changing their communities through public service, and the Jefferson Awards’ “S. Roger Horchow Award for Greatest Public Service by a Private Citizen.”

Best graduated Phi Beta Kappa from Yale College in 1998.

 

Kathleen Black  
Kathleen Dynan Black, MBA, Director, Government Strategy, Pfizer Inc.

Kathleen Dynan Black, MBA is Director, Government Strategy at Pfizer and has more than 25 years of pharmaceutical experience in federal and state healthcare programs, including 340B Drug Pricing Program and Medicaid Drug Rebate Program. Kathleen has developed and executed methodology assumptions, policies and procedures in support of government pricing, contracting, reporting and compliance.

Ronald Bone  
Ronald N. Bone, HDA Consultant, Ronald N. Bone Consulting LLC

Ron Bone is a consultant in the area of Pharmaceutical Traceability and is currently focusing on the implementation of the U.S. 2013 Drug Quality and Security Act. Ron retired from McKesson Corporation where he held the position of Senior Vice President, Distribution Support. His responsibilities included Regulatory Affairs and leading McKesson's product security initiatives through the use of electronic track and trace.

Ron spent 41 years with McKesson Corporation in various operations, sales and financial management positions. He was a member of the of the GS1 Process Oversight Committee, a member of the Leadership Teams of GS1 Global Healthcare and GS1 US Healthcare, and was a member of the Industry Relations Council for the Healthcare Distribution Management Association (HDMA). In 2008, Bone testified before the U.S. House of Representatives, Energy and Commerce Committee as an industry expert on anti-counterfeiting. In 2007, he was the recipient of HDMA’s Nexus Award, which is the industry’s highest honor recognizing leadership, exemplary service and professional excellence.

Ron received his BS and MBA degrees from San Jose State University.

Randy Bradley  
Randy V. Bradley, Ph.D., Assistant Professor of Information Systems and Supply Chain Management, University of Tennessee

Dr. Randy V. Bradley is an Assistant Professor of Information Systems and Supply Chain Management in the Haslam College of Business at The University of Tennessee. He holds a Ph.D. in Management of Information Technology (IT) and Innovation, an M.S. in Management Information Systems, and a B.S. in Computer Engineering, all from Auburn University. As a supply chain and healthcare IT strategist and researcher, Dr. Bradley’s expertise includes the strategic application of business analytics and IT in the supply chain, with an emphasis on the healthcare sector. Dr. Bradley has nearly 20 years of experience in the IT space, with approximately 15 years devoted to healthcare. He has held a number of positions in private business and has operated as an independent consultant providing advisory services to a variety of organizations in the public and private arenas. Some of Dr. Bradley’s business background includes consulting on IT outsourcing transitions, large-scale systems integration projects, and supply chain transformation initiatives. He has consulted for a variety of organizations, including General Motors Locomotive Division, Alabama Department of Transportation, Pratt & Whitney, Ford Healthcare, Northwell Health (formerly North Shore Long Island Jewish Health System), and various agencies within the U.S. Department of Defense.

Dr. Bradley has published nearly 30 articles and book chapters on the strategic application of business analytics and IT in the supply chain, and has presented his research at over 70 national and international practitioner and academic meetings and conferences. He is a highly sought-after speaker, and he has presented at numerous academic, professional, and corporate conferences and events. Additionally, Dr. Bradley has been recognized for his excellence in teaching, his leadership in promoting diversity and inclusion in academia, and his impact in industry as evidenced by numerous awards and recognitions.

As a member of the Association for Healthcare Resource & Materials Management (AHRMM), Association for Information Systems (AIS), Council of Supply Chain Management Professionals (CSCMP), Decision Sciences Institute (DSI), and the National Association of Black Accountants (NABA), he serves as an advocate for health IT and its interplay between other areas of healthcare, such as supply chain, financial/revenue cycle management, and analytics.

Marisa Brown  
Marisa Brown, Senior Principal Research Lead, Supply Chain Management, American Productivity & Quality Center (APQC)

Marisa Brown has more than 25 years of experience in business, research, writing, speaking, and consulting. Currently, she focuses on the in-depth needs of APQC’s members in supply chain management and product development as she develops and oversees APQC's supply chain management research agenda. She leads APQC’s supply chain team that conducts research to provide insights into benchmarks, best practices, and process improvements in supply chain planning, procurement, logistics, manufacturing, product development, and innovation. Marisa writes and publishes relevant content on APQC's Knowledge Base, the APQC blog, and third-party sites.  
Since joining APQC in 1996, Marisa has led several of APQC’s key growth initiatives. Prior to her current role, she was the director of APQC's Research Services department and before that was the founding director of APQC’s Knowledge Center. She has led some of APQC’s largest research projects and served as project manager, client manager, subject matter expert, and co-author on numerous projects. She was a senior program manager for APQC’s Open Standards Benchmarking® in supply chain, innovation, and product development. And prior to that she led APQC’s Collaborative Learning group and oversaw APQC’s annual multi-client research projects, taking consortium studies from initial market development through delivery and completion. She also helped establish APQC’s services for education institutions and has managed education research projects on topics such as assessing learning outcomes and institutional budgeting.
Marisa has written more than two dozen popular APQC research reports including Understanding Millennials in the Supply Chain,Evaluating Strategic Investments in High-Potential Finance Talent, Blueprint for Success: Procurement, Open Innovation: Enhancing Idea Generation Through Collaboration,  and New Product Development: Embracing an Adaptable Process. A frequent media contributor, she has provided interviews or penned articles for publications including Supply Chain Management Review, CFO.com, SupplyChainBrain, Paytech, IT World, Spend Matters, Supply & Demand Chain Executive, and many others. She has spoken at numerous different conferences including most recently those belonging to APQC, Project Management Institute (PMI), PDMA, KMWorld, and SPE’s International Polyolefins Conference.
Prior to joining APQC, Marisa received extensive training in ISO 9000 quality system implementation and was responsible for its development and supervision at a San Antonio lighting manufacturing company, where she was also the director of marketing.
Marisa earned her Master of Business Administration degree with highest honors from The University of Texas at Austin Graduate School of Business, where she was a Dean’s Award recipient. She also earned her Bachelor of Business Administration degree with highest honors from The University of Texas at Austin, majoring in honors business and finance.

Jon Brown  
Jon Brown, PharmD, Manager-Pharmacy Purchasing and Logistics, Indiana University Health

Scott Buchanan  
Scott Buchanan, Deputy Director, National Infrastructure Coordination Center, Department of Homeland Security, Office of Infrastructure Protection

Gregory Bylo  
Gregory Robert Bylo, Vice President, Healthcare, GS1 US

James Callahan  
James G. Callahan, Senior Director, Global Business Resilience, AmerisourceBergen Corporation

James G. Callahan joined AmerisourceBergen (ABC) four years ago and is responsible for leading the development, implementation and continued management of the Global Business Resilience (GBR) Program for all ABC business units and affiliates. The GBR program provides the centralized governance, tools and assurance processes to integrate Incident/Crisis Management, Business Continuity and IT High Availability/Disaster Recovery under a single, enterprise-wide strategic initiative.

Jim is a Certified Business Continuity Professional (CBCP), with over 20 years of experience in the field. He previously led Business Continuity and Disaster Recovery programs at AstraZeneca, Quest Diagnostics and GlaxoSmithKline.

In addition to his responsibilities at ABC, Jim is accredited by the National Board on Fire Service Professional Qualifications as a Firefighter, Fire Officer and Fire Service Instructor, and serves his community as Deputy Chief of the Black Rock Volunteer Fire Company.

Robert Celeste  
Robert Celeste, Founder, Center for Supply Chain Studies

Bob Celeste’s deep understanding and knowledge of the healthcare supply chain, including current standards and technologies, along with his ability to harness his expertise and innovate around the complexities of track-and-trace implementation, serialization and regulatory compliance, has made him a trusted industry partner.

Along with his work with both state and federal regulators, Bob often serves as an advisor to the FDA, State Boards of Pharmacy and other governing organizations. Most recently he was tapped as an advisor to the USAID and international regulators on the identification and tracking of drugs and medical supplies.

Bob launched the Center for Supply Chain Studies in 2015 to continue his practice of utilizing strategic simulations to address the challenges and demands of the supply chain. His expertise extends across many industries, including pharmaceutical, consumer goods, fresh foods, aerospace, automotive, specialty chemicals and others.

Prior to founding the Center, Bob was Senior Director at GS1 US, where he worked with industry on standards-based, item-level traceability and was the lead in developing the first DSCSA implementation guideline.

BJ Centers  
BJ Centers, Senior Director, Contract Services, Apexus, LLC

BJ Centers is Senior Director of Distributor Contracting at Apexus, the HRSA-designated 340B Prime Vendor, where he oversees relationships with 28 authorized distributors to ensure that covered entities have access to 340B drugs. In this role, he supports wholesalers and distributors in 340B compliance issues and challenges as it relates to the supply chain. BJ also manages the Apexus Manufacturer Refund Service, facilitating manufacturer refunds of 340B pricing overcharges to covered entities in the form of credits through covered entity distributor pharmacy ordering accounts.

Throughout his 40-year career, working with group purchasing organizations in the healthcare industry, BJ has served in sales, operations and management roles at pharmaceutical wholesalers. He has held various management positions at both large and small pharmaceutical manufacturers, where he was responsible for national and managed accounts. His specialties include: controlled distribution service development; real-time unit-dosing strategies; acute and non-acute care class of trade program/service development; web-based contract compliance and procurement modeling; government contracting; and securing national contracts for brand and generic pharmaceuticals.

Christopher Clement  
Christopher Clement, Senior Portfolio Executive, Apexus, LLC

Chris has worked for Apexus going on four years, and is responsible for many of Apexus’ key authorized distributor partners, as well as the Apexus Generics Program, and educating industry partners around 340B and the Prime Vendor Program. He continues to expand his impact within the Prime Vendor through his collaboration with the education team and the award-winning 340B University OnDemand training program. Chris also has recently become a 340B Apexus Certified Expert (ACE).

Prior to joining Apexus, Chris built his career through 13 years with AmerisourceBergen as a subject matter expert on the generic pharmaceutical marketplace, as well as a field sales coach, trainer, analyst and key account contact. His diverse background in the wholesaler industry gives him unique insight into the generics marketplace, and in understanding the distributor/340B relationship.

David Colombo  
David Colombo, Director, Life Sciences Advisory Services, KPMG, LLP

David Colombo is a Director in KPMG’s Advisory Services practice with more than 25 years of operational, engineering and IT experience in supply chain execution in the pharmaceutical industry, including both clinical and commercial chains. His responsibilities range from defining solution strategy through implementation and operational transformation with a focus on order-to-cash and purchase-to-pay processes, warehousing and distribution operations, and supply chain security.

Prior to joining KPMG in 2013, David was the serialization implementation leader for a Top-10 global pharmaceutical company. His industry experience included technical and operational leadership positions in supply chain, distribution, information technology and clinical trials logistics. He was an active contributor as a member of the EMVO serialization technical work stream, the HDA bar coding task force and the PDSA consortium. He has implemented serialization and traceability solutions in Turkey, China, S. Korea, Argentina, U.S. and multiple EU member states, leveraging his experience with ERP and WMS systems, serialization applications and GS1 standards for product and location identification.

Barry Conlon  
Barry Conlon, CEO, Overhaul

Barry is the CEO and Founder of Overhaul, an Austin based technology company providing real-time visibility and risk management solutions designed to protect product integrity and bring compliance to the global transportation industry. With over 30 years of supply chain security experience, Barry is considered one of the originators of modern-day supply chain security standards and best practices which have been adopted by shippers of high-value freight worldwide.

Larry Cote  
Larry P. Cote, Partner, Quarles & Brady LLP

Kevin Currier  
Kevin Currier, Analyst, Pharmaceutical Security Institute

Jeffery Denton  
Jeffery W. Denton, Senior Director, Global Secure Supply Chain, AmerisourceBergen Corporation

Jeff Denton is currently Senior Director, IT Global Secure Supply Chain at AmerisourceBergen. With over 30 years of experience in the wholesale distribution business, Jeff has held positions of increasing responsibility in finance, procurement, contracts and chargebacks as well as Information Technology.

Over the last 12 years, Jeff has been very involved in a variety of aspects around the supply chain security initiative. In addition, he has participated in numerous standards-activities within HDA and GS1-US/Global.

His current responsibilities include Enterprise IT solutions for AmerisourceBergen’s Global Secure Supply Chain program. Jeff serves at the IT lead and is the key liaison across all of the various business units – aligning implementation with standardization.

Matthew DiLoreto  
Matthew DiLoreto, Vice President, State Government Affairs, Healthcare Distribution Alliance

As HDA’s Vice President, State Government Affairs, Matthew DiLoreto coordinates HDA's nationwide state government affairs efforts, while maintaining and developing relationships with key stakeholders as well as state policymakers and law makers throughout the country. Matt also coordinates closely with HDA’s members to develop, implement and execute effective advocacy strategies addressing state legislative and regulatory issues affecting the pharmaceutical supply chain.

Prior to joining the HDA team, DiLoreto served as the Senior Director of State Government Affairs for the National Community Pharmacists Association (NCPA) which represents the interests of approximately 22,000 pharmacy providers and owners nationwide. His responsibilities at NCPA included developing and executing NCPA's state legislative strategy, while working closely with the association's many state and federal partners across the nation. DiLoreto also was a registered federal lobbyist and actively advanced many of NCPA's federal legislative and regulatory initiatives. During his years at NCPA DiLoreto was responsible for supporting state efforts resulting in more than fifty enacted state laws based upon NCPA model state legislation. Such laws primarily focused on reforming pharmacy reimbursement and drug pricing practices, and on providing for a fair and accessible medication delivery marketplace.

Before moving to the Washington D.C. area, Matt advocated for the Pennsylvania Pharmacists Association in Harrisburg, Pennsylvania, as the Director, Government Affairs and also represented the Pennsylvania Dental Association.

Dawn Doggett  
Dawn M. Doggett, Director of National Accounts, Trade, GPO & Federal, Sandoz

Dawn Doggett, MBA, is the Director of National Accounts at Sandoz BioPharmaceuticals, a division of Novartis, where she is responsible for Biosimilar Contracting and Strategy Development for the Acute Care and Oncology GPOs, Federal Market, and Distribution. Her team launched the first biosimilar in the U.S. and has contributed to positioning Sandoz as a leader in the biosimilar marketplace.  Dawn has spent 24 years in the pharmaceutical industry in various roles which include sales leadership, account and supply chain management excellence, state government affairs and public policy.